Sort by
Refine Your Search
-
, announces an open competition for the position Research software engineer Workplace: RECETOX, Faculty of Science, Masaryk University in Brno, Czech Republic Type of Contract: temporary position with a 1-year
-
to development of hematological malignancies Department: Institute of Medical Genetics and Genomics Description: Hematological malignancies are closely related to various types of somatic mutations in blood cells
-
Department: Jan Křivánek Research Group: Dental Development and Regeneration – Faculty of Medicine Deadline: 31 Jan 2026 Start date: April 2026 or upon agreement Job type: full-time Job field
-
working hours Support for further education and professional development Benefits package: 6 weeks of paid vacation, medical insurance, financial contribution to meal and kindergarten/pension scheme
-
how it influences the spread of attitudes and behaviors within and between groups. The project combines theoretical development with empirical work, including longitudinal data collection and school
-
collaboration No teaching duties (teaching possible upon interest) Career development support (grant mentoring, publishing support, conference travel, potential internships) Flexible working hours The option of a
-
procedure for the position of: Assistant or Assistant Professor at the Department of Physical Activities and Health Sciences The Faculty of Sports Studies at Masaryk University is a dynamically developing
-
professional experience in the field of research on microorganisms. The Head of the Czech Collection of Microorganisms will be responsible for the management and development of the collection, ensuring its
-
at the Faculty of Science, Masaryk University, Kamenice 5, Brno, is engaged in basic and applied research into the metabolism of microorganisms, animals, and plants, and the development of (bio)analytical methods
-
on immune cells and hematological malignancies. We aim to understand how changes in genome structure and regulation contribute to the development and progression of leukemia. Our new teammate will be